Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of ASP1707 and Methotrexate in RA
NCT02867306Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of opigolix in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Infinity and Maximum Plasma Concentration. Started Jul 2016; status: completed.
02
Drugs
opigolix
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02867306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02867306.